Feasibility of Gemcitabine plus Oxaliplatin in Advanced Hepatocellular Carcinoma Patients with Child-Pugh B Cirrhosis
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Feasibility of Gemcitabine plus Oxaliplatin in Advanced Hepatocellular Carcinoma Patients with Child-Pugh B Cirrhosis
Authors
Keywords
-
Journal
ONCOLOGY
Volume 84, Issue 1, Pages 32-38
Publisher
S. Karger AG
Online
2012-10-19
DOI
10.1159/000342763
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sarcopenia in patients (pts) with hepatocelluar carcinoma (HCC).
- (2017) J. Meza-Junco et al. JOURNAL OF CLINICAL ONCOLOGY
- Sarcopenia Predicts Early Dose-Limiting Toxicities and Pharmacokinetics of Sorafenib in Patients with Hepatocellular Carcinoma
- (2012) Olivier Mir et al. PLoS One
- Safety and efficacy of sorafenib in hepatocellular carcinoma: the impact of the Child-Pugh score
- (2011) A. Hollebecque et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Phase 2 trial of bevacizumab, capecitabine, and oxaliplatin in treatment of advanced hepatocellular carcinoma
- (2011) Weijing Sun et al. CANCER
- The Significance of Early Alpha-Fetoprotein Level Changes in Predicting Clinical and Survival Benefits in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib
- (2011) T. Yau et al. ONCOLOGIST
- An exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity
- (2010) Carla M. M. Prado et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Assessing the Quality of Initial Consultations Regarding Adjuvant Colon Cancer Therapy
- (2010) Hanna K. Sanoff et al. Clinical Colorectal Cancer
- Tolerance and outcome of patients with unresectable hepatocellular carcinoma treated with sorafenib
- (2010) Violaine Ozenne et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Feasibility of oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX-4) in cirrhotic or liver transplant patients: experience in a cohort of advanced hepatocellular carcinoma patients
- (2010) Romain Coriat et al. INVESTIGATIONAL NEW DRUGS
- Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment
- (2009) C. M.M. Prado et al. CLINICAL CANCER RESEARCH
- Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma
- (2008) Amani Asnacios et al. CANCER
- Utilisation du sorafénib (Nexavar®) dans le traitement du carcinome hépatocellulaire : recommandations Prodige Afef
- (2008) V. Boige et al. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
- Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
- (2008) Carla MM Prado et al. LANCET ONCOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation